Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Oslo, Norway, August 29, 2016 -- Photocure ASA hosted on August 25 an educational event in New York aimed at institutional investors and analysts, which focused on the treatment of bladder cancer....
-
Oslo, Norway, August 24, 2016: Photocure ASA (OSE: PHO), announces that its partner and exclusive distributor, Juno Pharmaceuticals Pty Ltd, have received marketing authorization approval (MAA) for...
-
Oslo, Norway, 23 August 2016: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology, reported a sales revenue growth of 18 % to...
-
Photocure will present its second quarter report on Tuesday 23 August 2016 at Hotel Continental, Oslo, Norway. Additionally, Dr. Daneshmand will provide an update on Hexvix/Cysview following the...
-
New Cysview kit has an improved design providing healthcare professionals with an improved, simplified, and easy-to-use product. Oslo, Norway, August 11, 2016: Photocure ASA (OSE: PHO), announces...
-
Oslo, Norway, August 2, 2016 -- Photocure ASA announced today a new systematic review and meta-analysis on the impact of Blue Light Cystoscopy (BLC) with Hexvix® (Hexaminolevulinate) - versus White...
-
Oslo, Norway, 6 July 2016: Photocure ASA will present its second quarter report on Tuesday 23 August 2016 at Hotel Continental, Norway, and is proud to announce Dr. Sia Daneshmand as keynote...
-
Oslo, Norway, 26 May 2016: Photocure ASA announces today that its Chief Operating Officer, Kathleen Deardorff, has resigned effective 1 June 2016 to pursue other career opportunities. Ms Deardorff...
-
Reference is made to the announcement on 23 May 2016 in respect of a capital increase of 34 134 new shares following exercise of employee share options in the company. The share capital increase has...
-
The board of directors of Photocure ASA has resolved a share capital increase as a consequence of employees exercising vested options granted under the company's employee incentive scheme. Upon...